Salem Investment Counselors’s West Pharmaceutical WST Stock Holding History

Salem Investment Counselors’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$597K	Sell	1,610 -6,894	-81%	-$2.43M	0.01%	284
2026 Q2	$3.05M	Buy	8,504 +451	+6%	+$138K	0.08%	142
2026 Q1	$2.02M	Buy	8,053 +1,492	+23%	+$371K	0.06%	159
2025 Q4	$1.81M	Buy	6,561 +2,843	+76%	+$778K	0.05%	162
2025 Q3	$975K	Buy	3,718 +1,168	+46%	+$284K	0.03%	214
2025 Q2	$558K	Buy	+2,550	New	+$545K	0.02%	267

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $343M AUM 13.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Salem Investment Counselors's WST Position: Q3 2026 in Review

Salem Investment Counselors reduced its West Pharmaceutical (WST) stake by 81% in Q3 2026, selling an estimated $2.43M and leaving 1,610 shares worth $597K. The position accounts for 0.01% of the portfolio, ranked #284.

Salem Investment Counselors first reported a position in WST in Q2 2025 and has held it in 6 quarters since. The position peaked at $3.05M in Q2 2026. 94 funds tracked by Wall St. Rank hold WST as of Q3 2026.

Salem Investment Counselors held 1,610 shares of West Pharmaceutical worth $597K as of Q3 2026.
Salem Investment Counselors sold 6,894 West Pharmaceutical shares in Q3 2026, an estimated $2.43M.
West Pharmaceutical made up 0.01% of Salem Investment Counselors's portfolio in Q3 2026, its #284 holding.
Salem Investment Counselors first reported a position in West Pharmaceutical in Q2 2025 and has held it in 6 quarters since.
Salem Investment Counselors's West Pharmaceutical position peaked at $3.05M in Q2 2026.
94 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on Salem Investment Counselors's 13F filing for Q3 2026, filed 13 Oct 2026.